Monoiodoinsulin. Preparation, purification, and characterization of a biologically active derivative substituted predominantly on tyrosine A14.
D000595:Amino Acid Sequence; D000818:Animals; D001681:Biological Assay; D001786:Blood Glucose; D002417:Cattle; D002852:Chromatography, Ion Exchange; D002918:Chymotrypsin; D002942:Circular Dichroism; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D004591:Electrophoresis, Polyacrylamide Gel; D006168:Guinea Pigs / Q000276:immunology; D006461:Hemolysis; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000302:isolation & purification*; D007330:Insulin Antibodies; D007455:Iodine; D007457:Iodine Radioisotopes; D051379:Mice; D008810:Mice, Inbred C57BL; D010084:Oxidation-Reduction; D011863:Radioimmunoassay; D012640:Seizures; D013056:Spectrophotometry, Ultraviolet; D013447:Sulfites; D014443:Tyrosine
D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies; D007457:Iodine Radioisotopes; D013447:Sulfites; D014443:Tyrosine; D007455:Iodine; D002918:Chymotrypsin